We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
Cap. Flow
-$4.13B
Cap. Flow %
-5.25%
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$409M
2
V icon
Visa
V
+$354M
3
AMD icon
Advanced Micro Devices
AMD
+$328M
4
META icon
Meta Platforms (Facebook)
META
+$317M
5
LMT icon
Lockheed Martin
LMT
+$316M

Sector Composition

Rank Sector Weight
1 Technology 11.61%
2 Consumer Discretionary 9.64%
3 Healthcare 8.17%
4 Industrials 8.1%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
2901
Ardelyx
ARDX
$1.03B
$100K ﹤0.01%
17,222
-301,223
-95% -$1.68M
GSBD icon
2902
Goldman Sachs BDC
GSBD
$1.08B
$100K ﹤0.01%
10,803
-55,211
-84% -$541K
TRUE
2903
DELISTED
TrueCar
TRUE
$100K ﹤0.01%
+44,262
New +$94.9K
LODE icon
2904
Comstock
LODE
$271M
$99.6K ﹤0.01%
+26,495
New +$90.1K
SEPN
2905
Septerna Inc
SEPN
$2.25B
$99.6K ﹤0.01%
+3,571
New +$85.3K
MYGN icon
2906
Myriad Genetics
MYGN
$301M
$99.4K ﹤0.01%
16,155
-128,790
-89% -$934K
GNLX icon
2907
Genelux
GNLX
$115M
$93.6K ﹤0.01%
+21,465
New +$116K
QNCX icon
2908
Quince Therapeutics
QNCX
$31.9M
$93K ﹤0.01%
+139
New +$69.9K
SRI icon
2909
Stoneridge
SRI
$198M
$92.1K ﹤0.01%
+15,904
New +$100K
VENU
2910
Venu Holding Corp
VENU
$116M
$91.3K ﹤0.01%
+10,848
New +$120K
SENS icon
2911
Senseonics Holdings Inc
SENS
$409M
$91.3K ﹤0.01%
+16,533
New +$115K
NIO icon
2912
PUT
NIO
NIO
$11.4B
$90.8K ﹤0.01%
17,800
GALT icon
2913
Galectin Therapeutics
GALT
$322M
$90.3K ﹤0.01%
+21,709
New +$114K
GPRO icon
2914
GoPro
GPRO
$105M
$89.9K ﹤0.01%
+63,724
New +$116K
KODK icon
2915
Kodak
KODK
$974M
$89.2K ﹤0.01%
+10,540
New +$78.8K
GRSD
2916
Grandstand Limited Ordinary Shares
GRSD
$68.4M
$88.5K ﹤0.01%
16,209
-836
-5% -$5.32K
DDD icon
2917
3D Systems Corp
DDD
$606M
$88K ﹤0.01%
+49,736
New +$121K
XMAX
2918
XMAX Inc
XMAX
$588M
$87.6K ﹤0.01%
+14,602
New +$82.3K
JBLU icon
2919
JetBlue
JBLU
$2.22B
$87.1K ﹤0.01%
19,147
-250,474
-93% -$1.14M
LTRX icon
2920
Lantronix
LTRX
$276M
$85.7K ﹤0.01%
+14,616
New +$76K
TLS icon
2921
Telos
TLS
$326M
$85.1K ﹤0.01%
+16,686
New +$104K
GME.WS
2922
GameStop Corp Warrants
GME.WS
$84.9K ﹤0.01%
+28,215
New +$87.5K
UROY
2923
Uranium Royalty Corp
UROY
$1.57B
$84.6K ﹤0.01%
+24,000
New +$93.9K
PLUG icon
2924
Plug Power
PLUG
$3.21B
$83.9K ﹤0.01%
42,592
+9,045
+27% +$23.6K
BNC
2925
CEA Industries
BNC
$100M
$81.1K ﹤0.01%
+12,626
New +$88.6K

Similar funds

Balyasny Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.

  • Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
  • Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
  • Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
  • Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
  • Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
  • Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
  • Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.